Evaluation of Bortezomib Use in Queensland Public Hospitals for the Treatment of Multiple Myeloma

被引：0
|
作者：
Walpole, Euan [1 ,2 ]
Mollee, Peter [1 ,2 ]
McPherson, Ian [2 ]
Loke, Crystal [1 ]
Hollingworth, Samantha [1 ]
机构：
[1] Univ Queensland, St Lucia, Qld, Australia
[2] Princess Alexandra Hosp, Canc Serv, Woolloongabba, Qld, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
264
引用
收藏
页码：164 / 165
页数：2
相关论文
共 50 条
  • [31] Bortezomib in the front-line treatment of multiple myeloma
    Richardson, Paul G.
    Mitsiades, Constantine
    Schlossman, Robert
    Ghobrial, Irene
    Hideshima, Teru
    Munshi, Nikhil
    Anderson, Kenneth C.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (07) : 1053 - 1072
  • [32] THROMBOTIC MICROANGIOPATHY ASSOCIATED WITH BORTEZOMIB TREATMENT IN MULTIPLE MYELOMA
    Pedraza, A.
    Gonzalez, A.
    Vicente Ayuso, C.
    Garcia Roa, M.
    Sanchez, L.
    Torres, W.
    Toral, S.
    Velazco, A.
    Bobes, A.
    Martinez, R. B. M.
    Mateo, M.
    HAEMATOLOGICA, 2016, 101 : 802 - 802
  • [33] Approval summary for bortezomib for injection in the treatment of multiple myeloma
    Bross, PF
    Kane, R
    Farrell, AT
    Abraham, S
    Benson, K
    Brower, ME
    Bradley, S
    Gobburu, JV
    Goheer, A
    Lee, SL
    Leighton, J
    Liang, CY
    Lostritto, RT
    McGuinn, WD
    Morse, DE
    Rahman, A
    Rosario, LA
    Verbois, SL
    Williams, G
    Wang, YC
    Pazdur, R
    CLINICAL CANCER RESEARCH, 2004, 10 (12) : 3954 - 3964
  • [34] Subcutaneous bortezomib for multiple myeloma treatment: patients' benefits
    Petrucci, Maria Teresa
    Finsinger, Paola
    Chisini, Marta
    Gentilini, Fabiana
    PATIENT PREFERENCE AND ADHERENCE, 2014, 8 : 939 - 946
  • [35] THROMBOTIC MICROANGIOPATHY ASSOCIATED TO BORTEZOMIB TREATMENT IN MULTIPLE MYELOMA
    Alexandra, Pedraza N.
    Ataulfo, Gonzalez
    Ayuso Carmen, Vicente
    Maria Paz, Martin
    Roa Maria, Garcia
    Noboa Lorena, Sanchez
    Cueto Adhemar, Velazco
    Fernandez Alejandro, Bobes
    Ana Maria, Gonzalez Salinas
    Maria Mayumi, Ibarra Morales
    Martinez Roberto, Trelles
    Morales Marta, Mateo
    Martinez Rafael, Martinez
    HAEMATOLOGICA, 2016, 101 : 101 - 101
  • [36] Bortezomib - first proteasome inhibitor for the treatment of multiple Myeloma
    Jurczyszyn, Artur
    Skotnicki, Aleksander B.
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2007, 11 (03): : 112 - 124
  • [37] Role of bortezomib for the treatment of previously untreated multiple myeloma
    Mateos, Maria-Victoria
    EXPERT REVIEW OF HEMATOLOGY, 2008, 1 (01) : 17 - 28
  • [38] Availability of antidotes for the treatment of acute poisoning in Queensland public hospitals
    Nissen, Lisa M.
    Wong, Kai Hang
    Jones, Anthea
    Roberts, Darren M.
    AUSTRALIAN JOURNAL OF RURAL HEALTH, 2010, 18 (02) : 78 - 84
  • [39] How best to use bortezomib (Velcade (R)) in multiple myeloma
    Rousselot, Philippe
    HEMATOLOGIE, 2006, 12 (05): : 300 - 300
  • [40] Emerging data on the use of anthracyclines in combination with bortezomib in multiple myeloma
    Voorhees, Peter M.
    Orlowski, Robert Z.
    CLINICAL LYMPHOMA & MYELOMA, 2007, 7 : S156 - S162
12345